Company
Phase Genomics
Ultra-long-range Sequencing Solutions for Genomics, Cytogenetics, Oncology & Microbiology - Phase Genomics
Also known as PHASE GENOMICS, INC.
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Legal name
- PHASE GENOMICS, INC.
- phasegenomics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Phase Genomics: Fueling Genomic Discovery. CytoTerra® Cytogenetics, ProxiMeta™ Metagenome Deconvolution, Proximo™ Genome Scaffolding
Funding snapshot
- Total raised
- $5.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $4.8M2023-03-14
Funding rounds
- Round, 2023
- $4.8M2023-03-14, SEC form D sold, 13 investors
- Round, 2017
- $1M2017-11-09, SEC form D sold, 4 investors
Products
- Web
- Proximo Platform
Loading relationship preview